Search results
Verve Therapeutics appoints new Chief Scientific Officer By Investing.com
Investing.com· 12 hours agoVerve Therapeutics, a biotechnology firm focused on gene editing treatments for cardiovascular ...
Alleged 'serial slingshot shooter' dies a day after bonding out of California jail
USA TODAY via Yahoo News· 13 hours agoPrince Raymond King, an 81-year-old man who was accused of being a "serial slingshot shooter," died...
Primary Sjögren Disease Promotes Premature Atherogenesis
Medscape· 1 day agoPatients with primary Sjögren disease with organ involvement were at a high risk for subclinical...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 18 hours agoVerve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing ...
Psoriasis and Cardiovascular Effects: A Vital Connection
Medscape· 2 days agoDr Joel Gelfand, Dr Michael Garshick, and Leah McCormick Howard discuss the connection between...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoBOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease ...
Arrowhead's much-anticipated cholesterol drug hits the mark again in phase 2 hyperlipidemia trial
FierceBiotech· 4 days agoArrowhead Pharmaceuticals’ hotly anticipated cholesterol disorder drug lowered key lipoproteins that...
Elderly ‘slingshot shooter,’ charged with terrorizing neighbors for years, dies days after arrest
New York Daily News· 10 hours agoAn elderly California man accused of terrorizing his community for years with a slingshot has died...
RNA inhibitor is shown safe and effective in reducing a wide range of cholesterol and triglyceride...
Medical Xpress· 3 days agoIn addition to seeing promising preliminary results related to safety and efficacy in clinical...
Where Will Amgen Be in 3 Years?
Motley Fool via Yahoo Finance· 3 days agoStill, there's a lot to like about the late-stage pipeline. In particular, its program evaluating a therapy called olpasiran could be useful in treating...
